Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted isoquinolines and phthalazines as inhibitors of phosphodiesterase type 10A

Substituted isoquinolines and phthalazines as inhibitors of phosphodiesterase type 10A

US Patent 9273068 · Granted Mar 1, 2016

Estimated economic value: $121,077,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modulators of the integrated stress pathway2021
Modulators of the integrated stress pathway2020
Modulators of the integrated stress pathway2020
Fused heterocyclic compounds as S1P modulators2020
Fused heterocyclic compounds as S1P modulators2020
Fused heterocyclic compounds as S1P modulators2020
Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of u2020
Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of u2020
Inhibitor compounds of phosphodiesterase type 10A2019
Inhibitor compounds of phosphodiesterase type 10A2019
Inhibitor compounds of phosphodiesterase type 10A2019
Inhibitor compounds of phosphodiesterase type 10A2019